Skip to main content

Seebri

Seebri
Used for COPD

Seebri Neohaler (glycopyrrolate) is an inhaler used to treat chronic obstructive pulmonary disease (COPD). Although it was FDA approved in 2015, it's no longer available in the United States because it was discontinued.

Reviewed by:
reviewerRobert Chad Hakim, PharmD, BCCCP
reviewerKristianne Hannemann, PharmD
Last reviewed on January 19, 2023
basics-icon

What is Seebri Neohaler (glycopyrrolate)?

What is Seebri Neohaler (glycopyrrolate) used for?

  • Chronic obstructive pulmonary disease (COPD)

Drug facts

Common BrandsSeebri Neohaler
Drug ClassAnticholinergic
Controlled Substance ClassificationNot a controlled medication
Generic StatusNo lower-cost generic available
AvailabilityDiscontinued
dosage-icon

Seebri Neohaler (glycopyrrolate) dosage

Typical dosage for Seebri Neohaler (glycopyrrolate)

alternatives-icon

What are alternatives to Seebri Neohaler (glycopyrrolate)?

There are a number of medications that your doctor can prescribe in place of Seebri Neohaler (glycopyrrolate). Compare a few possible alternatives below.
Seebri Neohaler (glycopyrrolate)
Used for:
  • Chronic obstructive pulmonary disease (COPD)
View prices
Used for:
  • Chronic obstructive pulmonary disease (COPD)
View prices
Used for:
  • Chronic obstructive pulmonary disease (COPD)
  • Asthma in people age 6 years and older - Spiriva Respimat only
$76.57Lowest GoodRx priceView prices

References

Best studies we found

Sunovion Pharmacueticals Inc. (2021). Seebri Neohaler- glycopyrrolate capsule [package insert]. DailyMed.

U.S. Food and Drug Administration. (n.d.). Drugs@FDA: FDA-approved drugs - Glycopyrrolate.

GoodRx Health has strict sourcing policies and relies on primary sources such as medical organizations, governmental agencies, academic institutions, and peer-reviewed scientific journals. Learn more about how we ensure our content is accurate, thorough, and unbiased by reading our editorial guidelines.